There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

PubMed ID:: 22581974

DOI:: 10.1093/jnci/djs243

ScienceOpen disciplines: Chemistry

Keywords: Antibodies, Monoclonal, Humanized,therapeutic use,Antineoplastic Combined Chemotherapy Protocols,Breast Neoplasms,chemistry,drug therapy,Female,Humans,Receptor, ErbB-2,analysis,Tumor Markers, Biological

Re: predictability of adjuvant trastuzumab benefit in N9831 patients using the ASCO/CAP HER2-positivity criteria.

Read this article at

Related collections

EPA CompTox Chemicals Dashboard

Author and article information

Journal

Comments

Comment on this article

Similar content 2,508

Cited by 6